DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Petrylak DP, Tangen CM, Hussain MH. et al.
Docetaxel and extramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.
N Engl J Med 2004; 27: 1513-1520
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.